|
LRRC70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.26959578803121E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37300187780443E-11 |
| Normal-vs-Stage2 |
7.60949969702551E-10 |
| Normal-vs-Stage3 |
3.47629702801555E-11 |
| Normal-vs-Stage4 |
1.98509997328955E-09 |
| Stage1-vs-Stage2 |
3.470600E-01 |
| Stage1-vs-Stage3 |
7.871600E-01 |
| Stage1-vs-Stage4 |
6.995200E-01 |
| Stage2-vs-Stage3 |
3.491800E-01 |
| Stage2-vs-Stage4 |
7.292000E-01 |
| Stage3-vs-Stage4 |
6.837200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28560512130593E-11 |
| Normal-vs-AfricanAmerican |
3.14319681393727E-11 |
| Normal-vs-Asian |
7.6507022939154E-11 |
| Caucasian-vs-AfricanAmerican |
1.331430E-01 |
| Caucasian-vs-Asian |
5.750400E-01 |
| AfricanAmerican-vs-Asian |
2.923000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.48759926388698E-11 |
| Normal-vs-Female |
2.48050469053851E-11 |
| Male-vs-Female |
7.505800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.03100003271351E-09 |
| Normal-vs-Extreme_Weight |
3.37400107852659E-11 |
| Normal-vs-Obese |
3.56249474364745E-11 |
| Normal-vs-Extreme_Obese |
8.51274606361585E-12 |
| Normal_Weight-vs-Extreme_Weight |
2.626600E-01 |
| Normal_Weight-vs-Obese |
2.078400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.137600E-02 |
| Extreme_Weight-vs-Obese |
6.912600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.516200E-01 |
| Obese-vs-Extreme_Obese |
2.795200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.73380207360674E-11 |
| Normal-vs-Age(41-60Yrs) |
3.70870001376034E-11 |
| Normal-vs-Age(61-80Yrs) |
4.43319825293997E-11 |
| Normal-vs-Age(81-100Yrs) |
7.92699239582362E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.759000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.484800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.785970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.237200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.474000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.149600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.1613045514689E-11 |
| Normal-VS-Type2 PRCC |
2.5787039170666E-11 |
| Normal-VS-KIRP CIMP |
4.60040006089457E-10 |
| Normal-VS-Unclassified PRCC |
8.34177171782358E-12 |
| Type1 PRCC-VS-Type2 PRCC |
8.252400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.840100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.694300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.203850E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.283420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.383960E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.57076607066165E-12 |
| Normal-vs-N1 |
2.94400059885902E-11 |
| Normal-vs-N2 |
4.09560163561196E-11 |
| N0-vs-N1 |
2.015600E-01 |
| N0-vs-N2 |
9.585800E-01 |
| N1-vs-N2 |
4.915200E-01 |
|
|
